New programme
The Scientist's Bridge: Essentials
On-demand online course for scientists moving into biotech sales and business development. Available now in English, with subtitles in English, Italian and German.
Discover the courseAuralis Biotech is a European biotech consultancy founded in Italy in 2025 by Dr. Giuseppina Sannino. We help startups, companies and investors understand and commercialize life science innovation, from diagnostics, agrifood and environment to drug discovery and every field of biology. Our services include business strategy, go-to-market and EU market entry, scientific content and websites, and expert calls. Working with clients in Europe, the US, the Middle East and Asia.
From the first call to ongoing support, with a dedicated point of contact. If needed, we bring in the specialist partners the project needs, from laboratories and CROs to legal and financial advisors.
We support biotech and life science companies across four stages of commercialization.
01 · Build
Positioning, value proposition and go-to-market strategy.
More about Build →02 · Grow
Business development, lead generation and scientific marketing.
More about Grow →03 · Scale
EU market entry, distributor networks and strategic partners.
More about Scale →04 · Exit
Commercial narrative, data room and acquirer identification.
More about Exit →Most projects need several skills at once: the science, the marketing and the business development. At Auralis they come together in one team, led by Dr. Giuseppina Sannino, a molecular biologist with a PhD in Cancer Biology and more than ten years of international experience in diagnostics, biopharma and molecular tools commercialization.
New programme
On-demand online course for scientists moving into biotech sales and business development. Available now in English, with subtitles in English, Italian and German.
Discover the course
In the press
CEO Weekly features our founder, Dr. Giuseppina Sannino, on building the bridge between science and the market. July 2026.
Read the interview
In the press
How point-of-need biotechnologies are redefining microbiological quality control in biopharma manufacturing. 2026.
Read the articlePartner technology
Microfluidic immunodiagnostic platform developed by Trustech Diagnostics. Quantitative, ELISA-grade results outside the central laboratory: 20 µL of sample, digital result in under an hour, TRL-7. Auralis Biotech is the commercial partner for the EliChip Early Adopter Program. For research and development use.
Discover EliChip